General - Press Releases

Date	Title	Company
11-Jul-2023	First Patient Dosed in SAR’514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma	Businesswire
10-Jul-2023	Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody	Businesswire
10-Jul-2023	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Applied Digital Corporation (APLD) on Behalf of Investors	Businesswire
10-Jul-2023	Novel gene delivery technology published and licensed exclusively to Cellinfinity Bio	Businesswire
10-Jul-2023	Half Year Median Technologies Liquidity Contract Statement Contracted With TP ICAP	Businesswire
10-Jul-2023	ImmunoTek Plasma Opens New Location in Queensbury	Businesswire
10-Jul-2023	Global Market for Electron Microscopes 2023-2033: Players Include Applied Materials, Coxem, Delmic, Delong Instruments and Gandeeva Therapeutics - ResearchAndMarkets.com	Businesswire
10-Jul-2023	WNDR® Alpine Launches Four New Hardgoods Models - Nocturne 88 and Vital 98 Backcountry Skis and Shepherd Solid and Split Snowboards	Businesswire
10-Jul-2023	Phase 1 Study Indicates Allogeneic Cytokine-Induced Memory-Like Natural Killer Cells Plus N-803 May Induce Tumor Regression in Advanced Head-and-Neck Cancer Patients	Businesswire
10-Jul-2023	Microsize Announces a Strategic Investment into The Solubility Company to Accelerate the US Expansion of a Novel, Disruptive Solubility Measuring Technology.	Businesswire
10-Jul-2023	Transaction Data Systems Announces Closing of Merger with Outcomes™	Businesswire
10-Jul-2023	GoodRx Appoints Dorothy Gemmell as Chief Commercial Officer	Businesswire
10-Jul-2023	ODDITY Announces Launch of Initial Public Offering	Businesswire
10-Jul-2023	Global Peptide Cancer Drug Market, Dosage, Price, Sales and Clinical Trials Insight to 2029 - ResearchAndMarkets.com	Businesswire
10-Jul-2023	Global BCR ABL Tyrosine Kinase Inhibitor Drug Market Report 2023: Clinical Insight On Approved BCR ABL Inhibitors Drugs - ResearchAndMarkets.com	Businesswire
10-Jul-2023	Heliogen Appoints Sagar Kurada as Chief Financial Officer and Head of Strategy	Businesswire
10-Jul-2023	Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)	Businesswire
10-Jul-2023	ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs	Businesswire
10-Jul-2023	MAIA Biotechnology Reports Updates on Preliminary Survival Data for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer	Businesswire
10-Jul-2023	Normunity appoints industry leader Debanjan Ray to Board of Directors	Businesswire